Abstract:Mononuclear phagocytes (MP) and T lymphocytes play a pivotal role in the host immune response to human immunodeficiency virus type 1 (HIV-1) infection. Regulation of such immune responses can be mediated, in part, through the interaction of the T-lymphocyte-expressed molecule CD40 ligand (CD40L) with its receptor on MP, CD40. Upregulation of CD40L on CD4+ peripheral blood mononuclear cells during advanced HIV-1 disease has previously been reported. Based on this observation, we studied the influence of CD40L-CD40 interactions on MP effector function and viral regulation in vitro. We monitored productive viral infection, cytokine and beta-chemokine production, and beta-chemokine receptor expression in monocyte-derived macrophages (MDM) after treatment with soluble CD40L. Beginning 1 day after infection and continuing at 3-day intervals, treatment with CD40L inhibited productive HIV-1 infection in MDM in a dose-dependent manner. A concomitant and marked upregulation of beta-chemokines (macrophage inhibitory proteins 1alpha and 1beta and RANTES [regulated upon activation normal T-cell expressed and secreted]) and the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) was observed in HIV-1-infected and CD40L-treated MDM relative to either infected or activated MDM alone. The addition of antibodies to RANTES or TNF-alpha led to a partial reversal of the CD40L-mediated inhibition of HIV-1 infection. Surface expression of CD4 and the beta-chemokine receptor CCR5 was reduced on MDM in response to treatment with CD40L. In addition, treatment of CCR5- and CD4-transfected 293T cells with secretory products from CD40L-stimulated MDM prior to infection with a CCR5-tropic HIV-1 reporter virus led to inhibition of viral entry. In conclusion, we demonstrate that CD40L-mediated inhibition of viral entry coincides with a broad range of MDM immune effector responses and the down-modulation of CCR5 and CD4 expression.

Short Communication: HIV-1 Infection Suppresses Circulating Viral Restriction Micrornas.

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

Microrna-155 is A Biomarker of T-Cell Activation and Immune Dysfunction in Hiv-1-Infected Patients

Interferon-induced Sterile Alpha Motif and Histidine/aspartic Acid Domain-Containing Protein 1 Expression in Astrocytes and Microglia is Mediated by Microrna-181A.

Progress of the Stady on Microrna in Regulating Innate Immunity

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

MicroRNA-181 Expression Regulates Specific Post-Transcriptional Level of SAMHD1 Expression in Vitro.

Two Cellular Micrornas, Mir-196B and Mir-1290, Contribute to HIV-1 Latency

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4 + T lymphocytes

Hsa-Mir-181-5p Inhibits Human Immunodeficiency Virus Type 1 Replication by Downregulating DDX3X Expression.

Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations

Downregulation of miRNA-26a by HIV-1 Enhances CD59 Expression and Packaging, Impacting Virus Susceptibility to Antibody-Dependent Complement-Mediated Lysis

The Role of MicroRNAs in HIV Infection

Critical Role of Micrornas in Host and Influenza A (H1N1) Virus Interactions.

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

Biological function of microRNA in HIV-1 infection:summary of recent progress

MicroRNA Binding to the HIV-1 Gag Protein Inhibits Gag Assembly and Virus Production.

MicroRNAs and exosomes: key players in HIV pathogenesis

miRNAs and human immunodeficiency virus type 1 infection:biomarkers and antiviral therapy

miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP.

Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T Cells: Identification of a Novel Antiviral MicroRNA